CA2816925C — Nucleic acid-containing lipid particles and related methods
Assigned to University of British Columbia · Expires 2023-01-10 · 3y expired
What this patent protects
The invention provides a lipid particle having a solid core, the lipid particle comprising one or more cationic lipids, one or more second lipids, and one or more nucleic acids, as well as devices and methods for making the lipid particles, and methods for using the lipid particl…
USPTO Abstract
The invention provides a lipid particle having a solid core, the lipid particle comprising one or more cationic lipids, one or more second lipids, and one or more nucleic acids, as well as devices and methods for making the lipid particles, and methods for using the lipid particles.
Drugs covered by this patent
- Onpattro (PATISIRAN SODIUM) · Alnylam Pharmaceuticals
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.